Clinical Trial Detail

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT04307576
Title	A Treatment Study Protocol for Participants 0-45 Years With Acute Lymphoblastic Leukaemia
Recruitment	Recruiting
Gender	both
Phase	Phase III
Variant Requirements	Yes
Sponsors	Mats Heyman
Indications	T-cell acute lymphoblastic leukemia B-cell acute lymphoblastic leukemia
Therapies	Imatinib Blinatumomab Inotuzumab ozogamicin
Age Groups:	adult \| child
Covered Countries	SWE \| NOR \| NLD \| LTU \| ISL \| IRL \| GBR \| FRA \| FIN \| EST \| DNK \| DEU \| BEL